Antares Vision Group

𝗔𝗻𝘁𝗮𝗿𝗲𝘀 𝗩𝗶𝘀𝗶𝗼𝗻 𝗚𝗿𝗼𝘂𝗽 𝗮𝘁 𝗚𝗖𝗖 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗔𝗳𝗳𝗮𝗶𝗿𝘀 𝗣𝗵𝗮𝗿𝗺𝗮 𝗦𝘂𝗺𝗺𝗶𝘁 𝟮𝟬𝟮𝟱 We were honored to participate as a valued exhibitor at the GCC Regulatory Affairs Pharma Summit 2025, a key event bringing together regulatory authorities, pharmaceutical leaders, and industry innovators from across the MENA region. Throughout the summit, we had the privilege of engaging with representatives from Ministries of Health and key stakeholders across the MENA region to discuss the future of pharmaceutical regulations and the transformative role of Track & Trace solutions in securing the pharma supply chain. Why are Track & Trace solutions essential? ✅ Ensuring drug authenticity & patient safety ✅ Combating counterfeit medicines ✅ Enhancing supply chain transparency ✅ Optimizing regulatory compliance & recall efficiency With increasing regulatory frameworks across the region, serialization and traceability are becoming indispensable tools for governments to strengthen pharmaceutical oversight and public health protection. At Antares Vision Group, we are committed to providing cutting-edge traceability and digitalization solutions to help regulators and the pharmaceutical industry ensure a safer, more transparent, and compliant ecosystem. We extend our gratitude to everyone we connected with during the summit—your insights and collaboration are instrumental in driving the future of pharma regulations. Let’s continue working together to shape a safer, more efficient healthcare landscape. Sebastian Neuwirth Rob Leonard Ahmad Awad - احمد عوض #GCCPharmaSummit #PharmaRegulations #TrackAndTrace #AntaresVisionGroup #RegulatoryCompliance #PharmaceuticalIndustry #HealthcareInnovation

𝗔𝗡𝗧𝗔𝗥𝗘𝗦 𝗩𝗜𝗦𝗜𝗢𝗡 𝗚𝗥𝗢𝗨𝗣: 𝗔𝗣𝗣𝗥𝗢𝗩𝗘𝗗 𝗖𝗢𝗡𝗦𝗢𝗟𝗜𝗗𝗔𝗧𝗘𝗗 𝗥𝗘𝗩𝗘𝗡𝗨𝗘𝗦 𝗔𝗡𝗗 𝗡𝗙𝗣 𝗔𝗦 𝗔𝗧 𝟯𝟭 𝗗𝗘𝗖𝗘𝗠𝗕𝗘𝗥 𝟮𝟬𝟮𝟰   4Q 2024 marked an important acceleration for the Group, with revenue growth of +22% and orders of +16%: these results will enable the Group to reach and exceed the targets set for FY 2024. Annual revenues amounted to €208 million, with +2% growth vs. FY 2023. The Net Financial Position (NFP) improved significantly to €84M, with the NFP/EBITDA ratio better than guidance.    “The robust acceleration in 4Q 2024 orders, sustained by the “One Company” organizational process and by a renewed commercial structure, guarantees a positive start to 2025,” explains Gianluca Mazzantini, CEO and General Manager of Antares Vision Group. See details here: https://lnkd.in/duK4SW_B   #AntaresVisiongroup #FinancialResults #Corporateperformance #Innovation #Growth #StrategicPlan 

Traceability, Consumer Engagement and Supply Chain Digitalization: 𝗗𝗜𝗔𝗠𝗜𝗡𝗗 𝗖𝗼𝗻𝗻𝗲𝗰𝘁 𝗶𝘀 𝗯𝗼𝗿𝗻   Antares Vision Group launches DIAMIND Connect, the new platform that combines advanced traceability and data management technologies and guarantees product monitoring throughout the entire life cycle, thus improving safety, transparency and sustainability of production processes.   Thanks to a Unique Digital Identity, every product is traceable from the raw material to the end consumer, reducing the risk of counterfeiting and promoting a more circular economy.   The platform is a new application of DIAMIND, Antares Vision Group's integrated and modular ecosystem of solutions.   “DIAMIND Connect is in line with the Group's consolidation and growth strategies. We are particularly proud of this launch, which strengthens our ability to support companies in the digital transformation of supply chains, ensuring security, efficiency and transparency at all levels," says Gianluca Mazzantini, CEO of Antares Vision Group. Read the press release: https://lnkd.in/dJMb3WGE   #AntaresVisionGroup #DIAMINDConnect #DIAMIND #Traceability #Innovation #Digitalisation #Sustainability

𝗔𝗻𝘁𝗮𝗿𝗲𝘀 𝗩𝗶𝘀𝗶𝗼𝗻 𝗚𝗿𝗼𝘂𝗽 𝘀𝗶𝗴𝗻𝘀 𝗮 𝗹𝗮𝗻𝗱𝗺𝗮𝗿𝗸 𝗮𝗴𝗿𝗲𝗲𝗺𝗲𝗻𝘁 𝘄𝗶𝘁𝗵 𝘁𝗵𝗲 𝗠𝗶𝗻𝗶𝘀𝘁𝗿𝘆 𝗼𝗳 𝗛𝗲𝗮𝗹𝘁𝗵 𝗼𝗳 𝗚𝘂𝗶𝗻𝗲𝗮-𝗕𝗶𝘀𝘀𝗮𝘂 We are honored to enter in a multi-year partnership with the Ministry of Health of Guinea-Bissau to implement a National Pharmaceutical Traceability System and a Digital Drug Catalogue. This project aims to improve the transparency and security of the pharmaceutical supply chain, ensuring compliance with regulatory standards.   Key features include:   ▶️ End-to-end traceability of medicines ▶️ Real-time data for regulatory monitoring ▶️ A centralized product catalog and national registry ▶️ Full visibility on imported pharmaceuticals   "This agreement represents an important step in supporting the digital transformation of Guinea-Bissau’s healthcare sector," said Gianluca Mazzantini, CEO of Antares Vision Group.   Sebastian Neuwirth Read the press release: https://lnkd.in/dfQAjsYZ   #AntaresVisionGroup #PharmaTraceability #Healthcare #GuineaBissau #SupplyChain #LifeSciences

𝗔𝗻𝘁𝗮𝗿𝗲𝘀 𝗩𝗶𝘀𝗶𝗼𝗻 𝗚𝗿𝗼𝘂𝗽 𝗮𝗹𝗹𝗮 𝗜𝘁𝗮𝗹𝗶𝗮𝗻 𝗠𝗶𝗱 𝗖𝗮𝗽 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 𝟮𝟬𝟮𝟱 𝗱𝗶 Mediobanca   Giunta alla settima edizione, la Italian Mid Cap Conference di Mediobanca svoltasi il 28 e 29 gennaio, ha rappresentato anche quest’anno un appuntamento consolidato per il confronto tra le società italiane di media capitalizzazione e gli investitori istituzionali. Per Antares Vision Group sono intervenuti il CFO, Stefano De Rosa e l’Head of Investor Relations & Corporate Communication, Alessandro Baj Badino.  Il tema principale dell’edizione 2025 è stata la digitalizzazione, un business centrale per Antares Vision Group, partner tecnologico d’eccellenza nella digitalizzazione e nell’innovazione per imprese e istituzioni. L’evento ha visto la partecipazione di 30 società quotate nel segmento Mid Cap, circa 100 investitori istituzionali e 53 fondi di investimento, sottolineando il forte interesse verso questo segmento di mercato. #AntaresVisionGroup #MBMidCapConference #Digitalizzazione

𝗔𝗻𝘁𝗮𝗿𝗲𝘀 𝗩𝗶𝘀𝗶𝗼𝗻 𝗚𝗿𝗼𝘂𝗽 𝗮𝘁 𝘁𝗵𝗲 "𝟵𝘁𝗵 𝗔𝗻𝗻𝘂𝗮𝗹 𝗣𝗼𝗹𝘆𝘁𝗲𝗺𝘀 𝗛𝗜𝗥 𝗜𝘁𝗮𝗹𝗶𝗮𝗻 𝗗𝗮𝘆" 𝗶𝗻 𝗙𝗿𝗮𝗻𝗸𝗳𝘂𝗿𝘁 Alessandro Baj Badino, Head of Investor Relations & Corporate Communication at Antares Vision Group, represented the company at the "9th Annual Polytems HIR Italian Day in Frankfurt," held yesterday, January 23rd. This event was a key opportunity for Antares Vision Group to strengthen its relationships with the European financial market, present its equity story, and update stakeholders on the progress of its strategic plan and the results achieved so far. During the event, Baj Badino was also interviewed by Isabella Bufacchi from Il Sole 24 Ore. In the article published today, he highlighted the importance of participating in an international event held in one of the main financial hubs of continental Europe. Lastly, the Group had the opportunity to present its business to Dr. Massimo Darchini, the Consul General of Italy in Frankfurt. #AntaresVisionGroup #InvestorRelations #PolytemsHIR #ItalianDay #Frankfurt #Innovation

Yesterday, January 22nd, our top management, Gianluca Mazzantini - CEO, Emidio Zorzella - Chairman and Co-Founder, and Massimo Bonardi - CTO and Co-Founder, participated in the World Economic Forum 2025 in Davos, Switzerland. This exclusive event is designed to foster dialogue, develop sustainable solutions, and explore cutting-edge trends that are transforming the IT sector today, with in-depth sessions on artificial intelligence, digital transformation, and future-oriented IT strategies. #worldeconomicforum #davos #AntaresVisionGroup #IT #artificialintelligence #digitaltransformation

Antares Vision Group has been selected among the “Best Picks 2025” by EQUITA, identified as one of the most promising Italian mid-caps. This choice reflects confidence in the company's growth potential, supported by a share price of €3.14. The broker's reasons for selecting us are: 1) Credible turnaround with already some evidence on costs and FCF, 2) Turnover expected back to expand nicely in 2025, 3) Solid portfolio with good diversification, with exposure with less cyclical sectors, 4) Pure restructuring story with an interesting valuation. Read more here: https://lnkd.in/dphye36i. #AntaresVisionGroup #BestPicks2025 #midcap #innovation #traceability #supplychaintrasparency #investors #IR #financialmarkets

Antares Vision Group: strategia e prospettive future In un articolo pubblicato il 4 gennaio scorso su Il Sole 24 Ore, il CEO di #AntaresVisionGroup Gianluca Mazzantini ha approfondito la fase di ristrutturazione strategica intrapresa dall’azienda e le prospettive legate al nuovo piano industriale, che sarà presentato nella primavera del 2025. Come sottolineato dal nostro CEO, “la prima fase, legata alla necessità di una ristrutturazione, può dirsi conclusa: abbiamo fermato l'emorragia di cassa, rinegoziato i covenant sul debito ma senza rivedere gli spread, siamo intervenuti sui tempi di consegna che si erano dilatati a dismisura. Infine, siamo dovuti intervenire, dolorosamente, anche sull'organico; ora però stiamo tornando ad assumere e dopo la ristrutturazione deve partire la fase di sviluppo”. Il focus sarà ora sulla crescita interna e sull’innovazione, con un’attenzione particolare ai settori del cosmetico, dell'agrifood e alla medicina RNA. Ringraziamo Meneghello Matteo per l’analisi dedicata al nostro percorso e al nostro posizionamento come player tecnologico. Leggi l'articolo completo: https://bit.ly/4h2ixGT #strategia #crescita #innovazione #tracciabilità

🎄✨ Season’s Greetings from Antares Vision Group! ✨🎄   2024 has been a year of great challenges, growth and changes.   Thanks to our partners, customers, and colleagues around the world for being part of this journey, which would not have been possible without their trust and support. Together, we look forward to the New Year with enthusiasm and determination, ready to keep shaping the future of industries.   We wish you a 2025 full of success and satisfaction.   Happy Holidays!